A 25-year-old Black man presented to the Tufts Medical Center emergency department with blurred vision in both eyes.The vision changes started in the left eye and progressed to involve the right eye 4 days later. He denied pain, photophobia, flashes or…
Author: Healio ophthalmology
Ophthalmology industry pipeline
Ophthalmic companies report updates on recent regulatory moves, studies and trials.The FDA approved Lytenava (bevacizumab-vikg, Outlook Therapeutics) for the treatment of neovascular age-related macular degeneration.The FDA granted 510(k) clearance for…
Company moves in ophthalmology for October
In October, several leadership changes were announced across the ophthalmic space.“Adding Justin to our team brings a depth of market access and reimbursement experience that aligns directly with Balance’s commercial needs.”The Deya platform aims to co…
Cataract surgery in highly myopic eyes
Cataract surgery in highly myopic eyes presents distinct challenges that require careful planning, surgical technique adjustment and close postoperative management.When the axial length exceeds 26 mm, the structural mechanics of the eye change complete…
Oral meets primary endpoint for non-infectious uveitis
Lisraya, an oral tyrosine kinase 2/Janus kinase inhibitor, achieved its primary endpoint in two phase 3 clinical trials investigating it for the treatment of noninfectious uveitis, according to a press release.“It has been nearly a decade since we last…
Contaminated, counterfeit eye drops being sold in US, FDA warns
Editor’s note: This is a developing news story. Please check back soon for updates.Several counterfeit eye drops, some of which were contaminated with bacteria, were recently found in U.S. stores, according to a notice from the FDA.Inauthentic eye drop…
Monovision planning not always tied to eye dominance
NEW ORLEANS — Determining the dominant eye should be one part of monovision planning but not the deciding rule on eye assignment, according to a speaker.In a presentation at Refractive Surgery Subspecialty Day at the American Academy of Ophthalmology m…
DEWS III update: Another bloated effort, little new to offer
While enjoying a rare extended and relaxed lunch break on a clinic day, I read an article on the latest Dry Eye Workshop offering from the Tear Film & Ocular Surface Society that included interviews of working group members and authors.Which led me to …
DEWS III update: Another bloated effort, little new to offer
While enjoying a rare extended and relaxed lunch break on a clinic day, I read an article on the latest Dry Eye Workshop offering from the Tear Film & Ocular Surface Society that included interviews of working group members and authors.Which led me to …
Myopia control ‘twice as fast’ with Essilor Stellest 2.0 lenses
Children wearing Essilor Stellest 2.0 lenses for 6 months had reductions in myopia progression comparable to changes in children who wore the original version of the glasses for a year, according to a press release from EssilorLuxottica.“The treatment …
Alcon acquires Neurotech Pharmaceuticals
Alcon has acquired Neurotech Pharmaceuticals and Encelto, its macular telangiectasia type 2 therapy, according to a press release.Alcon paid $550 million in the acquisition of Neurotech and could make contingent payments based on commercial milestones,…
Phase 2 clinical trial of EC-104 for DME meets primary endpoint
A phase 2 clinical trial investigating EC-104, a fluocinolone acetonide extended-release intravitreal implant for the treatment of diabetic macular edema, met its primary endpoint, according to a press release from Eclipse Life Sciences.As Healio previ…
Duravyu misses primary endpoint in second phase 3 wet AMD trial
Editor’s note: This is a developing news story. Please check back soon for updates.A second pivotal phase 3 trial of Duravyu in wet age-related macular degeneration failed to meet its primary endpoint, according to a press release from EyePoint Pharmac…
Select over-the-counter skin products contain undisclosed, prescription-strength steroid
A prescription-only, superpotent corticosteroid was found in one-third of select over-the-counter products purchased online in the United States for inflammatory skin conditions, according to a study published in JAMA Network Open.Products that were te…
Mitigate early symptoms, signs of repetitive strain injury
Click here to read the Healio Exclusive, “Practice good ergonomics early in career to avoid work-related injuries.”Practicing ophthalmology is mentally and physically stressful. To sustain a long and rewarding career, management of both is critically i…
Mitigate early symptoms, signs of repetitive strain injury
Click here to read the Healio Exclusive, “Practice good ergonomics early in career to avoid work-related injuries.”Practicing ophthalmology is mentally and physically stressful. To sustain a long and rewarding career, management of both is critically i…
How do you set yourself up for ergonomic success?
Click here to read the Healio Exclusive, “Practice good ergonomics early in career to avoid work-related injuries.”Now that I am in the middle of my career and approaching 51 years old, I feel like my body does not bounce back as well as it used to.I f…
How do you set yourself up for ergonomic success?
Click here to read the Healio Exclusive, “Practice good ergonomics early in career to avoid work-related injuries.”Now that I am in the middle of my career and approaching 51 years old, I feel like my body does not bounce back as well as it used to.I f…
Practice good ergonomics early in career to avoid injuries
Click here to read the At Issue to this Healio Exclusive, “Practice good ergonomics early in career to avoid work-related injuries.”For ophthalmologists, occupational pain can start early.For Cynthia Matossian, MD, FACS, discomfort arose fewer than 5 y…
Practice good ergonomics early in career to avoid injuries
For ophthalmologists, occupational pain can start early.For Cynthia Matossian, MD, FACS, discomfort arose fewer than 5 years into her career. She said surgeons often find themselves in similar positions over the course of their routine work, and repeat…